Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Previously Untreated FLT3-Mutated AML

January 28th 2020

CPX-351 for Secondary AML

January 28th 2020

Sequencing Strategies for Later-Line Therapy

January 28th 2020

Venetoclax-Based Chemotherapy Combinations in AML

January 28th 2020

The DYNAMO Later-Line Regimen

January 28th 2020

Managing Venetoclax-Associated Toxicity in AML

January 28th 2020

Treatment Options After Second-Line Relapse

January 28th 2020

Venetoclax-Based Regimens for Unfit Patients with AML

January 28th 2020

Relapsed/Refractory Treatment: The MAGNIFY Regimen

January 28th 2020

Determining Second-Line Therapy in FL

January 28th 2020

Hypomethylating Agents for AML

January 28th 2020

QUAZAR: Oral Azacitidine Maintenance in AML

January 28th 2020

Phase III GALLIUM Results and Maintenance Therapy

January 28th 2020

Immunochemotherapy Decision Factors

January 28th 2020

Decision Making on Consolidation Therapy for AML

January 28th 2020

Assessment of Fitness for AML Induction Chemotherapy

January 28th 2020

When to Initiate Therapy for Follicular Lymphoma

January 28th 2020

The Importance of Risk Assessment

January 28th 2020

AML Induction Strategy and Molecular Testing

January 28th 2020

Molecular Testing for AML

January 28th 2020